Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Clinical trial NCT02077192 · COMPLETED
Trial details
- NCT number
- NCT02077192
- Sponsor
- Rigel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2020-06-02
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.